New resolution on medicinal products and medical devices in the TTIP

Health technologies

Today, TACD releases a new policy resolution on medicinal products and medical devices (considered as health technologies by WHO) in the Trans-Atlantic Trade and Investment Partnership (TTIP). The resolution offers a set of recommendations to the EU and US negotiators, stressing that TTIP should under no circumstances reinforce the monopoly power of pharmaceutical corporations, limit the freedom …

Read More →

How to achieve coherence between trade and public health in TTIP?

By Zoltan Massay-Kosubek The author, who is Policy Coordinator at the European Public Health Alliance (EPHA) argues that trade liberalisation policy can both support public health goals and undermine them. The potential for economic growth and higher incomes enable wider access to healthier lifestyles, while increased availability of cheaper processed foods, tobacco and alcohol can promote further …

Read More →